Invention Grant
- Patent Title: Targeted replacement of endogenous T cell receptors
-
Application No.: US17390673Application Date: 2021-07-30
-
Publication No.: US11331346B2Publication Date: 2022-05-17
- Inventor: Theodore Lee Roth , Eric Shifrut , Alexander Marson , Cristina Puig Saus , Antoni Ribas
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C07K14/725 ; C12N9/22 ; C12N15/113 ; C12N15/85 ; C12N15/90
Abstract:
Provided herein are methods and compositions for editing the genome of a human T cell. In some embodiments, a heterologous T cell receptor (TCR)-β chain and a heterologous TCR-α chain are inserted into exon 1 of a TCR subunit constant gene in the genome of the T cell.
Public/Granted literature
- US20210353678A1 TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS Public/Granted day:2021-11-18
Information query
IPC分类:
